Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Performance evaluation of the Sysmex DI-60 overview application for tumor cell detection in body fluid samples.

Yamatani K, Tabe Y, Ai T, Kimura K, Takemura H, Tsuchiya K, Yang H, Konishi A, Uchihashi K, Horii T, Miida T, Ohsaka A.

Int J Lab Hematol. 2019 Apr 29. doi: 10.1111/ijlh.13039. [Epub ahead of print] No abstract available.

PMID:
31034145
2.

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.

Kitamura H, Tabe Y, Ai T, Tsuchiya K, Yuri M, Misawa S, Horii T, Kawaguchi A, Ohsaka A, Kimura S.

PLoS One. 2019 Mar 5;14(3):e0207170. doi: 10.1371/journal.pone.0207170. eCollection 2019.

3.

Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine.

Tabe Y, Saitoh K, Yang H, Sekihara K, Yamatani K, Ruvolo V, Taka H, Kaga N, Kikkawa M, Arai H, Miida T, Andreeff M, Spagnuolo PA, Konopleva M.

Sci Rep. 2018 Nov 15;8(1):16837. doi: 10.1038/s41598-018-35198-6.

4.

Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).

Fujisawa S, Ueda Y, Usuki K, Kobayashi H, Kondo E, Doki N, Nakao T, Kanda Y, Kosugi N, Kosugi H, Kumagai T, Harada H, Shikami M, Maeda Y, Sakura T, Inokuchi K, Saito A, Nawa Y, Ogasawara M, Nishida J, Kondo T, Yoshida C, Kuroda H, Tabe Y, Maeda Y, Imajo K, Kojima K, Morita S, Komukai S, Kawaguchi A, Sakamoto J, Kimura S.

Int J Clin Oncol. 2019 Apr;24(4):445-453. doi: 10.1007/s10147-018-1368-2. Epub 2018 Nov 12.

5.

Formation and dynamics of the aggregates of cholesteric double-twist cylinders.

Bono S, Maruyama Y, Tabe Y.

Soft Matter. 2018 Dec 12;14(48):9798-9805. doi: 10.1039/c8sm01565a.

PMID:
30398276
6.

Correction: Low-dose ionizing radiation exposure represses the cell cycle and protein synthesis pathways in in vitro human primary keratinocytes and U937 cell lines.

Sekihara K, Saitoh K, Yang H, Kawashima H, Kazuno S, Kikkawa M, Arai H, Miida T, Hayashi N, Niyonsaba F, Sasai K, Tabe Y.

PLoS One. 2018 Oct 5;13(10):e0205581. doi: 10.1371/journal.pone.0205581. eCollection 2018.

7.

Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes.

Tsuchiya K, Tabe Y, Ai T, Ohkawa T, Usui K, Yuri M, Misawa S, Morishita S, Takaku T, Kakimoto A, Yang H, Matsushita H, Hanami T, Yamanaka Y, Okuzawa A, Horii T, Hayashizaki Y, Ohsaka A.

PLoS One. 2018 Oct 3;13(10):e0202429. doi: 10.1371/journal.pone.0202429. eCollection 2018.

8.

Paget's disease derived in situ from reserve cell hyperplasia, squamous metaplasia, and squamous cell carcinoma of the esophagogastric junction: a case report.

Sano A, Sakurai S, Komine C, Tabe Y, Saito K, Fukasawa T, Kiriyama S, Yamamoto H, Tani M, Naitoh H, Shirabe K, Kuwano H.

Surg Case Rep. 2018 Jul 25;4(1):81. doi: 10.1186/s40792-018-0489-1.

9.

Low-dose ionizing radiation exposure represses the cell cycle and protein synthesis pathways in in vitro human primary keratinocytes and U937 cell lines.

Sekihara K, Saitoh K, Yang H, Kawashima H, Kazuno S, Kikkawa M, Arai H, Miida T, Hayashi N, Niyonsaba F, Sasai K, Tabe Y.

PLoS One. 2018 Jun 18;13(6):e0199117. doi: 10.1371/journal.pone.0199117. eCollection 2018. Erratum in: PLoS One. 2018 Oct 5;13(10):e0205581.

10.

An inhibitor of oxidative phosphorylation exploits cancer vulnerability.

Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, Chang E, Ciurea S, Cross JB, Czako B, Deem A, Daver N, de Groot JF, Dong JW, Feng N, Gao G, Gay J, Do MG, Greer J, Giuliani V, Han J, Han L, Henry VK, Hirst J, Huang S, Jiang Y, Kang Z, Khor T, Konoplev S, Lin YH, Liu G, Lodi A, Lofton T, Ma H, Mahendra M, Matre P, Mullinax R, Peoples M, Petrocchi A, Rodriguez-Canale J, Serreli R, Shi T, Smith M, Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q, Muller F, DePinho RA, Toniatti C, Draetta GF, Heffernan TP, Konopleva M, Jones P, Di Francesco ME, Marszalek JR.

Nat Med. 2018 Jul;24(7):1036-1046. doi: 10.1038/s41591-018-0052-4. Epub 2018 Jun 11.

PMID:
29892070
11.

Evaluation of cell count and classification capabilities in body fluids using a fully automated Sysmex XN equipped with high-sensitive Analysis (hsA) mode and DI-60 hematology analyzer system.

Takemura H, Ai T, Kimura K, Nagasaka K, Takahashi T, Tsuchiya K, Yang H, Konishi A, Uchihashi K, Horii T, Tabe Y, Ohsaka A.

PLoS One. 2018 Apr 26;13(4):e0195923. doi: 10.1371/journal.pone.0195923. eCollection 2018.

12.

Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia.

Zhang Q, Shi C, Han L, Jain N, Roberts KG, Ma H, Cai T, Cavazos A, Tabe Y, Jacamo RO, Mu H, Zhao Y, Wang J, Wu SC, Cao F, Zeng Z, Zhou J, Mi Y, Jabbour EJ, Levine R, Tasian SK, Mullighan CG, Weinstock DM, Fruman DA, Konopleva M.

Oncotarget. 2018 Jan 17;9(8):8027-8041. doi: 10.18632/oncotarget.24261. eCollection 2018 Jan 30.

13.

Novel flowcytometry-based approach of malignant cell detection in body fluids using an automated hematology analyzer.

Ai T, Tabe Y, Takemura H, Kimura K, Takahashi T, Yang H, Tsuchiya K, Konishi A, Uchihashi K, Horii T, Ohsaka A.

PLoS One. 2018 Feb 9;13(2):e0190886. doi: 10.1371/journal.pone.0190886. eCollection 2018.

14.

Formation of Concentric Silica Nanogrooves Guided by the Curved Surface of Silica Particles.

Hara S, Hirota K, Tabe Y, Wada H, Shimojima A, Kuroda K.

Langmuir. 2018 Jan 30;34(4):1733-1741. doi: 10.1021/acs.langmuir.7b03777. Epub 2018 Jan 8.

PMID:
29272588
15.

Leukemia Stem Cells Microenvironment.

Tabe Y, Konopleva M.

Adv Exp Med Biol. 2017;1041:19-32. doi: 10.1007/978-3-319-69194-7_3.

PMID:
29204827
16.

Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.

Kanayama M, Hayano T, Koebis M, Maeda T, Tabe Y, Horie S, Aiba A.

Prostate. 2017 Nov;77(15):1489-1498. doi: 10.1002/pros.23425. Epub 2017 Sep 14.

PMID:
28905415
17.

Unidirectional rotation of cholesteric droplets driven by UV-light irradiation.

Bono S, Sato S, Tabe Y.

Soft Matter. 2017 Sep 27;13(37):6569-6575. doi: 10.1039/c7sm00982h.

PMID:
28900643
18.

Antimicrobial cathelicidin peptide LL‑37 induces NET formation and suppresses the inflammatory response in a mouse septic model.

Hosoda H, Nakamura K, Hu Z, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, Nagaoaka I.

Mol Med Rep. 2017 Oct;16(4):5618-5626. doi: 10.3892/mmr.2017.7267. Epub 2017 Aug 17.

PMID:
28849130
19.

Comparison of the Analytical Performance Between cobas EGFR Assay and PCR-Clamp Method in the Detection of EGFR Mutations in Japanese Non-Small Cell Lung Cancer Patients.

Ai T, Yuri M, Tabe Y, Kakimoto A, Morishita S, Tsuchiya K, Takamochi K, Kodama Y, Takahashi F, Shigeki M, Horii T, Suzuki K, Takahashi K, Miida T, Ohsaka A.

Clin Lab. 2017 May 1;63(5):1021-1026. doi: 10.7754/Clin.Lab.2017.161223.

PMID:
28627833
20.

Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.

Tabe Y, Tafuri A, Sekihara K, Yang H, Konopleva M.

Expert Opin Ther Targets. 2017 Jul;21(7):705-714. doi: 10.1080/14728222.2017.1333600. Epub 2017 Jun 9. Review.

PMID:
28537457
21.

Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1.

Sekihara K, Saitoh K, Han L, Ciurea S, Yamamoto S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H, Miida T, Andreeff M, Konopleva M, Tabe Y.

Oncotarget. 2017 May 23;8(21):34552-34564. doi: 10.18632/oncotarget.16602.

22.

Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide.

Hu Z, Murakami T, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, Nagaoka I.

Int J Mol Med. 2017 Mar;39(3):549-558. doi: 10.3892/ijmm.2017.2870. Epub 2017 Jan 27.

23.

[Workshop -A New Era of Specialists in Clinical Laboratory Medicine].

Tabe Y, Kotani K.

Rinsho Byori. 2017 Feb;65(2):205-209. Japanese.

PMID:
30762988
24.

Bone Marrow Adipocytes Facilitate Fatty Acid Oxidation Activating AMPK and a Transcriptional Network Supporting Survival of Acute Monocytic Leukemia Cells.

Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma N, Ikeo K, Mogushi K, Shikami M, Ruvolo V, Ishizawa J, Hail N Jr, Kazuno S, Igarashi M, Matsushita H, Yamanaka Y, Arai H, Nagaoka I, Miida T, Hayashizaki Y, Konopleva M, Andreeff M.

Cancer Res. 2017 Mar 15;77(6):1453-1464. doi: 10.1158/0008-5472.CAN-16-1645. Epub 2017 Jan 20.

25.

Performance Evaluation of a Novel Fully Automated Real-Time Reverse Transcriptase-Polymerase Chain Reaction Kit for the Detection of Norovirus.

Hosoda T, Uehara Y, Matsuda N, Kawase' Y, Tanei M, Haba Y, Nakamura A, Tabe Y, Naito T, Ohsaka A.

Rinsho Byori. 2016 Dec;64(12):1347-1352.

PMID:
30653896
26.

Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients.

Idei M, Tabe Y, Hamada C, Miyake K, Takemura H, Io H, Wakita M, Horii T, Tomino Y, Ohsaka A, Miida T.

Clin Chim Acta. 2016 Nov 1;462:65-70. doi: 10.1016/j.cca.2016.08.009. Epub 2016 Aug 13.

PMID:
27531412
27.

[Research Ethics -The Case of Juntendo University Hospital-].

Tabe Y.

Rinsho Byori. 2016 Jul;64(7):816-820. Review. Japanese.

PMID:
30695471
28.

Impact of Clotting Condition on the Measurement of Circulating MicroRNAs in Serum.

Hayashi K, Tabe Y, Miida T.

Clin Lab. 2016;62(3):471-5.

PMID:
27156338
29.

Comparison of prothrombin time tests used in the monitoring of edoxaban and their evaluation as indicators of the reversal effect.

Iba T, Emmi M, Hiki M, Nagayama M, Aihara K, Tabe Y, Yuri M, Ohsaka A.

Int J Hematol. 2016 Jun;103(6):665-72. doi: 10.1007/s12185-016-1975-5. Epub 2016 Mar 16.

PMID:
26984594
30.

Poorly cohesive adenocarcinoma of the ampulla of Vater: a case report.

Yamauchi H, Sakurai S, Hagiwara K, Yoshida T, Tabe Y, Fukasawa T, Kiriyama S, Fukuchi M, Naitoh H, Kuwano H.

Surg Case Rep. 2016 Dec;2(1):15. doi: 10.1186/s40792-016-0142-9. Epub 2016 Feb 15.

31.

Induced smectic phases of stoichiometric liquid crystal mixtures.

Sugisawa SY, Tabe Y.

Soft Matter. 2016 Mar 28;12(12):3103-9. doi: 10.1039/c6sm00038j.

PMID:
26898174
32.

ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.

Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Ma W, Lee HC, Orlowski R, Sarbassov dos D, Lorenzi PL, Huang X, Neelapu SS, McDonnell T, Miranda RN, Wang M, Kantarjian H, Konopleva M, Davis RE, Andreeff M.

Sci Signal. 2016 Feb 16;9(415):ra17. doi: 10.1126/scisignal.aac4380.

33.

Integrative genomic and proteomic analyses identifies glycerol-3-phosphate acyltransferase as a target of low-dose ionizing radiation in EBV infected-B cells.

Tabe Y, Hatanaka Y, Nakashiro M, Sekihara K, Yamamoto S, Matsushita H, Kazuno S, Fujimura T, Ikegami T, Nakanaga K, Matsumoto H, Ueno T, Aoki J, Yokomizo T, Konopleva M, Andreeff M, Miida T, Iwabuchi K, Sasai K.

Int J Radiat Biol. 2016;92(1):24-34. doi: 10.3109/09553002.2015.1106021. Epub 2015 Nov 19.

PMID:
26809544
34.

Stability of a double twisted structure in spherical cholesteric droplets.

Yoshioka J, Ito F, Tabe Y.

Soft Matter. 2016 Feb 28;12(8):2400-7. doi: 10.1039/c5sm02838h.

PMID:
26806762
35.

Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction.

Iba T, Hashiguchi N, Nagaoka I, Tabe Y, Kadota K, Sato K.

Intensive Care Med Exp. 2015 Dec;3(1):36. doi: 10.1186/s40635-015-0072-z. Epub 2015 Dec 29.

36.

Evaluation of abdominal circumference and salivary amylase activities after unsedated colonoscopy using carbon dioxide and air insufflations.

Kiriyama S, Naitoh H, Fukuchi M, Yuasa K, Horiuchi K, Fukasawa T, Tabe Y, Yamauchi H, Suzuki M, Yoshida T, Saito Y, Kuwano H.

J Dig Dis. 2015 Dec;16(12):747-51. doi: 10.1111/1751-2980.12302.

PMID:
26639093
37.

2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.

Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Nishiyama R, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S.

PLoS One. 2015 Nov 4;10(11):e0141946. doi: 10.1371/journal.pone.0141946. eCollection 2015.

38.

The efficacy of an internet-based e-learning system using the CellaVision Competency Software for continuing professional development.

Horiuchi Y, Tabe Y, Kasuga K, Maenou I, Idei M, Horii T, Miida T, Ohsaka A.

Clin Chem Lab Med. 2016 Apr;54(4):e127-31. doi: 10.1515/cclm-2015-0641. No abstract available.

PMID:
26479345
39.

The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression.

Harada M, Benito J, Yamamoto S, Kaur S, Arslan D, Ramirez S, Jacamo R, Platanias L, Matsushita H, Fujimura T, Kazuno S, Kojima K, Tabe Y, Konopleva M.

Oncotarget. 2015 Nov 10;6(35):37930-47. doi: 10.18632/oncotarget.6122.

40.

Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.

Tabe Y, Kojima K, Yamamoto S, Sekihara K, Matsushita H, Davis RE, Wang Z, Ma W, Ishizawa J, Kazuno S, Kauffman M, Shacham S, Fujimura T, Ueno T, Miida T, Andreeff M.

PLoS One. 2015 Sep 4;10(9):e0137210. doi: 10.1371/journal.pone.0137210. eCollection 2015.

41.

Clinical Performance Evaluation of a High-Risk Human Papillomavirus Genotyping Test "Clinichip HPV" Using Cervical Scrape Specimens.

Yamada H, Tabe Y, Ishii K, Terao Y, Yamashita Y, Horii T, Takeda S, Ohsaka A.

Clin Lab. 2015;61(7):851-5.

PMID:
26299088
42.

Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux.

Yuri M, Tabe Y, Tsuchiya K, Sadatsuki R, Aoki J, Horii T, Iba T, Ohsaka A.

Clin Appl Thromb Hemost. 2016 Jul;22(5):453-8. doi: 10.1177/1076029615595878. Epub 2015 Jul 15.

PMID:
26177660
43.

Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.

Ishizawa J, Kojima K, Hail N Jr, Tabe Y, Andreeff M.

Pharmacol Ther. 2015 Sep;153:25-35. doi: 10.1016/j.pharmthera.2015.06.001. Epub 2015 Jun 3. Review.

44.

Role of Microenvironment in Resistance to Therapy in AML.

Tabe Y, Konopleva M.

Curr Hematol Malig Rep. 2015 Jun;10(2):96-103. doi: 10.1007/s11899-015-0253-6. Review.

45.

A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia.

Yamauchi H, Sakurai S, Nakazawa N, Yoshida T, Tabe Y, Saitoh K, Fukasawa T, Kiriyama S, Naitoh H, Kuwano H.

Int Surg. 2015 Mar;100(3):562-7. doi: 10.9738/INTSURG-D-14-00074.1.

46.

Comparative study of the anti-leukemic effects of imatinib mesylate, Glivec™ tablet and its generic formulation, OHK9511.

Yokoo M, Kubota Y, Tabe Y, Kimura S.

Biol Pharm Bull. 2015;38(3):411-6. doi: 10.1248/bpb.b14-00652. Epub 2015 Jan 8.

47.

Recurrent, spontaneous esophageal ruptures associated with antiphospholipid antibody syndrome: report of a case.

Naitoh H, Fukuchi M, Kiriyama S, Fukasawa T, Tabe Y, Yamauchi H, Yoshida T, Saito K, Hagiwara K, Kuwano H.

Int Surg. 2014 Nov-Dec;99(6):842-5. doi: 10.9738/INTSURG-D-13-00204.1.

48.

Intrahepatic biliary dilatation caused by a small simple hepatic cyst: report of a case.

Naitoh H, Fukasawa T, Fukuchi M, Kiriyama S, Tabe Y, Yamauchi H, Suzuki M, Yoshida T, Sakurai S, Kuwano H.

Int Surg. 2014 Nov-Dec;99(6):753-6. doi: 10.9738/INTSURG-D-13-00153.1.

49.

Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs.

Ando H, Mochiki E, Ohno T, Yanai M, Toyomasu Y, Ogata K, Tabe Y, Aihara R, Nakabayashi T, Asao T, Kuwano H.

World J Gastroenterol. 2014 Nov 14;20(42):15691-702. doi: 10.3748/wjg.v20.i42.15691.

50.

Performance evaluation of the digital cell imaging analyzer DI-60 integrated into the fully automated Sysmex XN hematology analyzer system.

Tabe Y, Yamamoto T, Maenou I, Nakai R, Idei M, Horii T, Miida T, Ohsaka A.

Clin Chem Lab Med. 2015 Feb;53(2):281-9. doi: 10.1515/cclm-2014-0445.

PMID:
25153399

Supplemental Content

Support Center